The Wastage Question: Where Policy Stops and Risk Begins
Not every graft can be perfectly matched to a wound, and that’s not new. What has changed is how those decisions are being evaluated — the rules have changed and the gap is where risk is now.
What Sustained Audit Pressure Is Doing to Wound Care
Audit pressure has been present for years, but it is now showing up more consistently across practices and more directly inside treatment decisions. These are the consequences of what that does to the industry.
What an NCD Would Actually Mean for Wound Care
An National Coverage Determination does not remove complexity from wound care but it does give that complexity a more stable structure. Here is where Bionavix is focused around that.
Race to the Bottom? What Pricing Pressure Is Doing to Wound Care
Lower pricing in wound care doesn’t reduce cost. It transfers responsibility and creates a more self-managed care system, which introduces greater risk for physicians. Here’s what that looks like.
Inventory as Liability: The Financial Exposure coming in January
January 2026 is not just the start of a new era in wound care. It marks the moment that the economics of skin-substitutes and wound barriers are rewritten in real time. What clinics purchased in good faith under one payment model may be billed under a completely different one—and the gap between those two is where the real exposure is.
The clinics that recognize this now will avoid the losses. Here’s a quick primer for those who want more.